Skip to main content
. 2020 Dec 31;9:e63199. doi: 10.7554/eLife.63199

Table 2. Open reading frames (ORFs) identified by fixation index (FST) as being significantly more similar in strains transmitted prenatally.

LD: Found to contain one of 33 hotspots of genetic linkage disequilibrium (Lassalle et al., 2016).

ORF LD Function
UL10 Y Putative membrane glycoprotein. Immunosuppressive, Impairs T cell function (Bruno et al., 2016)
UL11 Y Membrane glycoprotein. Modulates T cell signalling/function (Gabaev et al., 2014; Arcangeletti et al., 2015)
UL13 Unknown function
UL4 Y Putative membrane glycoprotein (Van Damme and Van Loock, 2014)
UL5 Putative membrane glycoprotein (Van Damme and Van Loock, 2014)
UL6 Y Putative membrane glycoprotein (Van Damme and Van Loock, 2014)
UL7 Y Membrane glycoprotein. Modulates chemo- and/or cytokine-signalling function (Pérez-Carmona et al., 2018)
UL8 Y Transmembrane glycoprotein. Inhibits proinflammatory cytokines (Pérez-Carmona et al., 2018)
US26 Unknown function
US27 Y Membrane glycoprotein. Activates CXCR4 signalling to increase human cytomegalovirus replication (Frank et al., 2019)
UL150A Fibroblast and epithelial cell entry (Houldcroft et al., 2016)
UL2 Putative membrane glycoprotein (Van Damme and Van Loock, 2014)
RL11 Y Membrane glycoprotein. Binds IgG Fc domain involved in immune regulation (Van Damme and Van Loock, 2014)
UL147 α-Chemokine homologue (Katoh and Standley, 2013; Paradis and Schliep, 2019)
UL40 Control of NK recognition (Heatley et al., 2013)
RL13 Y Glycoprotein, repression of replication, binds IgG domain immune regulation (Stanton et al., 2010; Cortese et al., 2012)
RL10 Membrane glycoprotein
UL57 Ss DNA binding protein (Van Damme and Van Loock, 2014)
UL50 Nuclear Egress complex. Reduces interferon-mediated antiviral effect (DeRussy et al., 2016)